The post-ACR/EULAR TREG Conference Analysis Program

  • Summarizes current trends in management and drug therapy
  • Reviews the significance of new foundational science and clinical research
  • Assesses which data are most relevant to the pharmaceutical industry
  • Delivers data-driven insights tailored for industry

The unique TREG Conference Analysis Program has been running since 2009. This exceptional program generates a comprehensive report presented by our respected faculty, offering deep clinical insight and critical analysis of the key data presented at ACR and EULAR each year.

Subscribers to this program receive

  • Strategic preconference analysis of the full EULAR and ACR databases, each comprising 2000+ abstracts
  • Daily in-depth clinical insights on the most meaningful abstracts presented at the meetings from our rheumatology experts with their own unique clinical viewpoint
  • In-person opportunities to network with opinion leaders and industry colleagues at our daily onsite analysis meetings
  • The conference analysis report presented at our onsite Educational Session, with opportunities to pose questions to the faculty regarding the data and its interpretation
  • Postmeeting deliverables, including a webcast of the full onsite Educational Session and a full copy of the slide presentation

Virtual conference services

The COVID-19 pandemic has presented challenges in terms of how we work and how we deliver care to our patients. During the pandemic, TREG rapidly and successfully adapted its format, taking our services to a virtual platform and continuing to provide the in-depth conference analysis and high-quality deliverables that our subscribers have come to expect from this exclusive program.

The added value of this new virtual format is that it allows our subscribers to share the program more widely with their colleagues, with further benefits such as daily highlights webcasts during the conference and an extended online, on-demand post conference Educational Session followed by a live Q&A with the TREG Section Leads.

MEET THE TREG PHYSICIANS

LEARN MORE